BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11437395)

  • 21. [A phase II study of irinotecan combined with cisplatin in non-small cell lung cancer. CPT-11 Lung Cancer Study Group].
    Nagao K; Fukuoka M; Fujita A; Kurita Y; Saito R; Niitani H; Negoro S; Katakami N; Nakano M
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):413-21. PubMed ID: 10740635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of a 3-week schedule of irinotecan combined with cisplatin in previously untreated extensive-stage small-cell lung cancer.
    Lee JE; Park HS; Jung SS; Kim JO; Kim SY
    Oncology; 2007; 73(1-2):76-80. PubMed ID: 18334853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study of docetaxel and irinotecan in patients with advanced non-small-cell lung cancer.
    Nogami N; Harita S; Ueoka H; Yonei T; Kiura K; Kamei H; Tabata M; Segawa Y; Gemba K; Tanimoto M
    Lung Cancer; 2004 Jul; 45(1):85-91. PubMed ID: 15196738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer.
    Takeda K; Takifuji N; Uejima H; Yoshimura N; Terakawa K; Negoro S
    Lung Cancer; 2002 Dec; 38(3):303-8. PubMed ID: 12445753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose escalation study of paclitaxel in combination with fixed-dose irinotecan in patients with advanced non-small cell lung cancer (JCOG 9807).
    Yamada K; Ikehara M; Tanaka G; Nomura I; Oshita F; Noda K
    Oncology; 2004; 66(2):94-100. PubMed ID: 15138360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
    Fujita A; Takabatake H; Tagaki S; Sekine K
    Cancer Chemother Pharmacol; 2000; 45(4):279-83. PubMed ID: 10755315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: phase II trial.
    Buffoni L; Dongiovanni D; Barone C; Fissore C; Ottaviani D; Dongiovanni V; Grillo R; Salvadori A; Birocco N; Schena M; Bertetto O
    Lung Cancer; 2006 Dec; 54(3):353-7. PubMed ID: 17049672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
    Langer CJ; Somer R; Litwin S; Feigenberg S; Movsas B; Maiale C; Sherman E; Millenson M; Nicoloau N; Huang C; Treat J
    J Thorac Oncol; 2007 Mar; 2(3):203-9. PubMed ID: 17410043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.
    Breathnach OS; Georgiadis MS; Schuler BS; Pizzella P; Llorens V; Kasturi V; Steinberg SM; O'Neil K; Takimoto CH; Johnson BE
    Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.
    Tomonaga N; Nakamura Y; Soda H; Nagashima S; Nakano H; Kinoshita A; Fukuda M; Fukuda M; Takatani H; Soejima Y; Oka M; Kohno S;
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):43-9. PubMed ID: 17717667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma.
    Socinski MA; Sandler AB; Israel VK; Gillenwater HH; Miller LL; Locker PK; Antonellini A; Elfring GL; Natale RB
    Cancer; 2002 Oct; 95(7):1520-7. PubMed ID: 12237921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
    Masuda N
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I study of irinotecan and infusional cisplatin for advanced non-small-cell lung cancer.
    Mori K; Ohnishi T; Yokoyama K; Tominaga K
    Cancer Chemother Pharmacol; 1997; 39(4):327-32. PubMed ID: 9025773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential chemotherapy with combination irinotecan and cisplatin followed by docetaxel for treatment-naïve patients with advanced non-small cell lung cancer.
    Mok TS; Ho S; Chan G; Ho WM; Wong H; Chan AT; Yeo W; Yim AP; Chak K; Lee Y; Lam KC
    J Thorac Oncol; 2007 Sep; 2(9):838-44. PubMed ID: 17805062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
    Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
    Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
    Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of irinotecan plus cisplatin for advanced non-small cell lung cancer].
    Han N; Liu ZW; Wang J; Zhang ZM
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):349-50. PubMed ID: 20159719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Irinotecan plus cisplatin for the treatment of advanced non-small cell lung cancer].
    Zhang XR; Zhu YZ; Xiu QY; Han FC; Liu DQ; Chu DT
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):777-9. PubMed ID: 17366795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer.
    Fujita A; Ohkubo T; Hoshino H; Takabatake H; Tagaki S; Sekine K; Abe S
    Br J Cancer; 2003 Sep; 89(6):1008-12. PubMed ID: 12966417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.